Liberator Medical Declares Cash Dividend of $0.03 per Share and Board Authorizes a 1,000,000 Share Buyback

Dividend Is to Be Paid to the Shareholders of Record at the Close of Business on July 8, 2013

Marketwired

STUART, FL--(Marketwired - June 14, 2013) - Liberator Medical Holdings, Inc. (LBMH) today announced that on June 13, 2013, its Board of Directors approved a cash dividend of $0.03 per common share to its shareholders and a buyback of up to 1,000,000 shares of its common stock. This is the second cash dividend paid to shareholders in 2013 and in the Company's history.

A cash dividend of $0.03 per common share will be paid on July 22, 2013, to all shareholders of record as of the close of business on July 8, 2013. The Company's policy is to pay a sustainable quarterly dividend to its shareholders. The Company's Board of Directors will evaluate on a quarterly basis the amount and timing of future dividends based on the Company's operating results, financial condition, capital requirements and general business conditions. The amount and timing of any future dividends may vary, and the payment of any dividend does not assure that the Company will be able to pay dividends in the future.

The 1,000,000 share buyback will be implemented at management's discretion and is subject to standard corporate buyback rules and regulations.

Stay up-to-date with current events by visiting Liberator Medical's website at www.liberatormedical.com or by joining the Company's E-Mail Alert List. Join by clicking the following link www.LBMH-IR.com

About Liberator Medical Holdings, Inc.

Liberator Medical Holdings, Inc.'s subsidiary, Liberator Medical Supply, Inc., established the Liberator brand as a leading national direct-to-consumer provider of quality medical supplies to Medicare-eligible seniors. An Exemplary Provider™ accredited by The Compliance Team, its unique combination of marketing, industry expertise and customer service has demonstrated success over a broad spectrum of chronic conditions. Liberator is recognized for offering a simple, reliable way to purchase medical supplies needed on a regular, ongoing, repeat-order basis, with the convenience of direct billing to Medicare and private insurance. Liberator's revenue primarily comes from supplying products to meet the rapidly growing requirements of general medical supplies, diabetes supplies, catheters, ostomy supplies and mastectomy fashions. Liberator communicates with patients and their doctors on a regular basis regarding prescriptions and supplies. Customers may purchase by phone, mail or internet, with repeat orders confirmed with the customer and shipped when needed.

Safe Harbor Statement

In this press release and in related comments by our management, our use of the words "expect," "anticipate," "possible," "potential," "target," "believe," "commit," "intend," "continue," "may," "would," "could," "should," "project," "projected," "positioned" or similar expressions is intended to identify forward-looking statements that represent our current judgment about possible future events. We believe these judgments are reasonable, but these statements are not guarantees of any events or financial results, and our actual results may differ materially due to a variety of important factors. Such risks and uncertainties may include, but are not limited to, regulatory limitations on the medical industry in general, working capital constraints, fluctuations in customer demand and commitments, fluctuation in quarterly results, introduction of new services and products, commercial acceptance and viability of new services and products, pricing and competition, reliance upon subcontractors and vendors, the timing of new technology and product introductions, and the risk of early obsolescence of our products. Liberator's most recent annual report on Form 10-K and quarterly reports on Form 10-Q provide information about these and other factors, which we may revise or supplement in future reports filed with the Securities and Exchange Commission.

Contact:
 

 Individual Investor Relations Contact
 WSR Communications
 772-219-7525
 IR@WSRcommunications.com
 http://wsrcommunications.ir.stockpr.com/liberatormedical

 Institutional Investor Contact
 Lyn Davis
 Littlebanc Advisors, LLC
 561-948-3005
 ld@littlebanc.com
 www.littlebanc.com

Rates

View Comments (0)